Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: Cancer Causes Control. 2009 Dec 18;21(4):643–648. doi: 10.1007/s10552-009-9485-x

Table 1.

Geometric mean of 25(OH)D concentrations (ng ml−1) in 20 volunteers, by centrifuging time, collection tube, and type of assay

2 h
Geometric mean
(range)
24 h
Geometric mean
(range)
72 h
Geometric mean
(range)
96 h
Geometric mean
(range)
All times combined
Geometric mean
(range)
Chemiluminescence immunoassay (CLIA/LIAISON®)
 No additive—serum 15.4 (6.4, 62.4) 16.3 (6.3, 64.5) 14.5 (6.6, 60.4) 15.1 (5.4, 59.0) 15.3 (5.4, 64.5)
 Heparin—plasma 16.1 (6.3, 61.6) 16.7 (6.1, 60.0) 15.3 (6.4, 56.1) 16.6 (6.6, 62.3) 16.1 (6.1, 62.3)
 EDTA—plasma 15.6 (6.3, 63.5) 14.5 (6.9, 59.4) 15.3 (7.0, 58.1) 15.7 (6.1, 56.6) 15.3 (6.1, 63.5)
 All tubes combined 15.7 (6.3, 63.5) 15.8 (6.1, 64.5) 15.0 (6.4, 60.4) 15.8 (5.4, 62.3) 15.6 (5.4, 64.5)
Radioimmunoassay (DiaSorin RIA)
 No additive—serum 16.0 (6.1, 59.2) 16.1 (6.7, 57.8) 16.7 (7.2, 68.2) 16.1 (5.9, 58.3) 16.2 (5.9, 68.2)
 Heparin—plasma 15.9 (5.4, 53.8) 16.4 (5.5, 58.5) 17.0 (7.6, 58.9) 16.9 (7.2, 59.1) 16.5 (5.4, 59.1)
 EDTA—plasma 15.5 (7.5, 56.2) 15.5 (5.0, 65.1) 16.1 (5.8, 58.3) 15.6 (5.3, 54.8) 15.7 (5.0, 65.1)
 All tubes combined 15.8 (5.4, 59.2) 16.0 (5.0, 65.1) 16.6 (5.8, 68.2) 16.2 (5.3, 59.1) 16.1 (5.0, 68.2)

Abbreviations used CLIA Chemiluminescence immunoassay; RIA Radioimmunoassay